Koyfin Home > Directory > Health Care > Amgen Inc > Repurchase of Common Stock

Amgen Inc Repurchase of Common Stock Chart (AMGN)

Amgen Inc annual/quarterly Repurchase of Common Stock from 2010 to 2020.
  • Amgen Inc Repurchase of Common Stock for the quarter ending June 06, 2020 was $-555m a -109.19% increase of 606m year over year
  • Amgen Inc Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-3,908m a -126.66% increase of 4,950m year over year
  • Amgen Inc Annual Repurchase of Common Stock for 2019 was $-7,839m a -128.60% increase of 10,081m from 2018
  • Amgen Inc Annual Repurchase of Common Stock for 2018 was $-17,920m a 81.30% decrease of -14,569m from 2017
  • Amgen Inc Annual Repurchase of Common Stock for 2017 was $-3,351m a 3.76% decrease of -126m from 2016
Other Cash Flow Metrics:
  • Amgen Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $3,194m a 14.62% increase of 467m year over year
  • Amgen Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $3,068m a 48.86% increase of 1,499m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN Repurchase of Common Stock Data

06/2020$-555m
03/2020$-961m
12/2019$-1,231m
09/2019$-1,161m
06/2019$-2,415m
03/2019$-3,032m
12/2018$-2,250m
09/2018$-1,729m
06/2018$-3,244m
03/2018$-10,697m

Annual AMGN Repurchase of Common Stock Data

2019$-7,839m
2018$-17,920m
2017$-3,351m
2016$-3,225m
2015$-2,268m
2014$-363m
2013$-832m
2012$-4,607m
2011$-8,315m
2010$-3,786m